查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1509636

2024 年臉部注射劑全球市場報告

Facial Injectable Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

臉部注射劑的市場規模預計在未來幾年將快速成長。 2028年，這一數字將以10.5%的複合年成長率成長至205億美元。預測期內的成長可歸因於對非手術程序的需求增加、更廣泛的應用、個人化和客製化選項、新興市場的成長、醫療保健趨勢以及生活方式偏好的變化等因素。在此期間預計的主要趨勢包括對非手術程序的需求持續成長、個性化治療選擇的擴大、強調聯合治療以改善結果、微創技術和設備的進步、對自然外觀和微妙飾面的偏好。更多。

人們對整容手術的興趣日益濃厚，預計將在未來幾年推動臉部注射劑市場的成長。整容手術包括旨在增強外觀且對身體自然結構影響最小的治療，比傳統手術侵入性更小，並且通常在門診病人進行。由於社會對外表的關注、醫學進步帶來的更安全、更容易的手術以及對自我完善和自信的日益成長的渴望，這種需求正在增加。臉部填充劑用於美容手術中，透過精確注射肉毒桿菌毒素或真皮填充劑等物質，暫時減少皺紋，增加特定區域的體積，並改善臉部輪廓。例如，2023年3月，英國美容整形外科醫生協會報告稱，2022年英國整容手術數量將比2021年增加102%，達到約31,057例。因此，整容手術需求的不斷成長正在推動臉部注射劑市場的成長。

臉部注射劑市場的主要企業正在透過長效透明質酸 (HA) 填充劑等產品進行創新，以滿足微創美容手術的需求，從而提供自然的效果和持久的效果。 HA 填充劑透過補充天然皮膚物質來恢復體積、撫平皺紋並增強臉部輪廓。例如，2023 年 1 月，Allergan plc 推出了 JUVEDERM VOLUX XC。這款 HA 填充劑專為 21 歲以上有中度至重度輪廓缺陷的人士收緊下巴輪廓而設計。 JUVEDERM VOLUX XC 對尋求非手術選擇的患者很有吸引力，因為它的效果永續長達 12 個月，並且可以在最少的恢復時間內提供自然的效果。在研究和高患者滿意度的支持下，這種填充劑可以讓您的美容專家製定客製化的治療計劃。

目錄

第1章執行摘要

第2章 市場特點

第3章 市場趨勢與策略

第4章宏觀經濟情景

  • 高通膨對市場的影響
  • 烏克蘭與俄羅斯戰爭對市場的影響
  • COVID-19 對市場的影響

第5章世界市場規模與成長

  • 全球臉部注射劑市場：促進因素與限制因素
    • 市場促進因素
    • 市場限制因素
  • 全球臉部注射劑市場表現：規模與成長，2018-2023
  • 全球臉部注射劑市場預測：規模和成長，2023-2028，2033F

第6章 市場細分

  • 全球臉部注射劑市場：按類型分類的表現和預測，2018-2023、2023-2028F、2033F
  • 肉毒桿菌毒素
  • 膠原蛋白
  • 玻尿酸
  • 烴基磷灰石鈣
  • 聚乳酸
  • 聚甲基丙烯酸甲酯微球（PMMA）
  • 脂肪注射
  • 其他類型
  • 全球臉部注射劑市場：按應用分類的表現和預測，2018-2023、2023-2028F、2033F
  • 減少皺紋
  • 拉皮
  • 痤瘡疤痕治療
  • 脂肪萎縮的治療
  • 唇部增強
  • 其他用途
  • 全球臉部注射劑市場：最終用戶的表現和預測，2018-2023、2023-2028F、2033F
  • 醫院及門診手術中心
  • 皮膚科/美容診所
  • 其他最終用戶

第 7 章 區域/國家分析

  • 全球臉部注射劑市場：按地區分類的績效與預測，2018-2023、2023-2028F、2033F
  • 全球臉部注射劑市場：按國家/地區分類的績效和預測，2018-2023、2023-2028F、2033F

第8章亞太市場

第9章 中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章 義大利市場

第20章 西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章加拿大市場

第26章 南美洲市場

第27章 巴西市場

第28章 中東市場

第29章 非洲市場

第30章 競爭格局及公司概況

  • 臉部注射劑市場：競爭格局
  • 臉部注射劑市場：公司簡介
    • AbbVie Inc.
    • Sanofi SA
    • Ipsen Pharma
    • Galderma SA
    • Merz Pharma GmbH & Co. KGaA

第31章 其他重大及創新企業

  • Sinclair Pharma Plc
  • Revance Therapeutics Inc.
  • Suneva Medical Inc.
  • Prollenium Medical Technologies
  • SciVision Biotech Inc.
  • Anteis SA
  • Anika Therapeutics Inc.
  • Q-Med AB
  • Bloomage BioTechnology
  • Medytox Inc.
  • Teoxane Laboratories
  • Alphaeon Corporation
  • BIOPLUS CO. LTD.
  • BioPolymer GmbH & Co. KG
  • Bioxis Pharmaceuticals

第32章競爭基準化分析

第 33 章. 競爭對手儀表板

第34章 重大併購

第35章前瞻性與潛力分析

第36章附錄

簡介目錄
Product Code: r18133

Facial injectables are cosmetic procedures that involve injecting substances into facial tissues to enhance features, diminish wrinkles, restore volume, or enhance overall appearance without surgery. These treatments are commonly used to address aging signs or achieve specific aesthetic goals, offering results that are temporary or semi-permanent.

The primary types of facial injectables include botulinum toxin, collagen, hyaluronic acid, calcium hydroxyapatite, polylactic acid, polymethyl-methacrylate microspheres (PMMA), fat injection, and others. Botulinum toxin is a neurotoxic protein used in cosmetic procedures to temporarily relax muscle activity, primarily for reducing facial wrinkles and lines. These injectables serve various purposes such as wrinkle reduction, facelifts, acne scar treatment, lipoatrophy treatment, lip enhancement, and more. They are used by different end-users including hospitals, ambulatory surgery centers, dermatology and cosmetic clinics, among others.

The facial injectable market research report is one of a series of new reports from The Business Research Company that provides facial injectable market statistics, including facial injectable industry global market size, regional shares, competitors with a facial injectable market share, detailed facial injectable market segments, market trends and opportunities, and any further data you may need to thrive in the facial injectable industry. This facial injectable market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The facial injectable market size has grown rapidly in recent years. It will grow from $12.45 billion in 2023 to $13.74 billion in 2024 at a compound annual growth rate (CAGR) of 10.4%. The increase during the historic period can be attributed to factors such as the growing aging population, increased consumer awareness, changes in beauty standards, regulatory approvals, and advancements in injection techniques.

The facial injectable market size is expected to see rapid growth in the next few years. It will grow to $20.50 billion in 2028 at a compound annual growth rate (CAGR) of 10.5%. The rise in the forecast period can be attributed to factors such as the increasing demand for non-surgical procedures, broader applications, personalization and customization options, growth in emerging markets, healthcare trends, and shifts in lifestyle preferences. Major trends expected in this period include sustained growth in the demand for non-surgical procedures, the expansion of personalized treatment options, a greater emphasis on combination therapies for improved outcomes, the advancement of minimally invasive techniques and devices, and a preference for natural-looking and subtle results.

The rising interest in cosmetic procedures is expected to drive the growth of the facial injectable market in the coming years. Cosmetic procedures encompass medical treatments aimed at enhancing appearance with minimal disruption to the body's natural structure, often less invasive than traditional surgeries and typically performed on an outpatient basis. This demand is increasing due to societal focus on appearance, safer and more accessible procedures enabled by medical advancements, and a growing desire for self-improvement and confidence boost. Facial injectables are used in cosmetic procedures to temporarily reduce wrinkles, add volume to specific areas, and improve facial contours through precise injection of substances such as botulinum toxin or dermal fillers. For example, in March 2023, a report from the British Association of Aesthetic Plastic Surgeons noted a 102% increase in cosmetic procedures in the UK in 2022, reaching around 31,057 procedures, compared to 2021. Thus, the rising demand for cosmetic procedures is fueling the growth of the facial injectable market.

Leading companies in the facial injectable market are innovating with products such as long-lasting hyaluronic acid (HA) fillers to meet the demand for minimally invasive aesthetic procedures offering natural-looking and enduring results. HA fillers restore volume, smooth wrinkles, and enhance facial contours by replenishing natural skin substances. For instance, in January 2023, Allergan plc introduced JUVEDERM VOLUX XC, an HA filler specifically designed to enhance jawline definition for individuals aged 21 and above with moderate to severe contour loss. Providing effects lasting up to twelve months, JUVEDERM VOLUX XC delivers natural-looking results with minimal downtime, appealing to patients seeking non-surgical options. Supported by research and high patient satisfaction, this filler enables customized treatment plans by cosmetic specialists.

In October 2022, Prollenium Medical Technologies acquired SoftFil for an undisclosed amount, expanding its product range and enhancing its position in the aesthetic medicine industry. This acquisition strengthens innovation and offers comprehensive solutions to practitioners for optimal patient outcomes. SoftFil, a France-based company, produces cosmetic products, aesthetic microcannulas, and facial injectable solutions, complementing Prollenium's portfolio.

Major companies operating in the facial injectable market are AbbVie Inc., Sanofi S.A., Ipsen Pharma, Galderma S.A., Merz Pharma GmbH & Co. KGaA, Sinclair Pharma Plc, Revance Therapeutics Inc., Suneva Medical Inc., Prollenium Medical Technologies, SciVision Biotech Inc., Anteis S.A., Anika Therapeutics Inc., Q-Med AB, Bloomage BioTechnology, Medytox Inc., Teoxane Laboratories, Alphaeon Corporation, BIOPLUS CO. LTD., BioPolymer GmbH & Co. KG, Bioxis Pharmaceuticals, Everest Pharmaceuticals

North America was the largest region in the facial injectable market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the facial injectable market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the facial injectable market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The facial injectable market consists of sales of platelet-rich plasma (PRP) injections, collagen stimulators, lip injections, and thread lifts. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Facial Injectable Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on facial injectable market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for facial injectable? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The facial injectable market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Botulinum Toxin; Collagen; Hyaluronic Acid; Calcium Hydroxyapatite; Polylactic Acid; Polymethyl-methacrylate Microspheres (PMMA); Fat Injection; Other Types
  • 2) By Application: Wrinkle Reduction; Facelift; Acne Scar Treatment; Lipoatrophy Treatment; Lip Enhancement; Other Applications
  • 3) By End-user: Hospitals And Ambulatory Surgery Centers; Dermatology And Cosmetic Clinics; Other End-Users
  • Companies Mentioned: AbbVie Inc.; Sanofi S.A.; Ipsen Pharma; Galderma S.A.; Merz Pharma GmbH & Co. KGaA
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Facial Injectable Market Characteristics

3. Facial Injectable Market Trends And Strategies

4. Facial Injectable Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Facial Injectable Market Size and Growth

  • 5.1. Global Facial Injectable Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Facial Injectable Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Facial Injectable Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Facial Injectable Market Segmentation

  • 6.1. Global Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Botulinum Toxin
  • Collagen
  • Hyaluronic Acid
  • Calcium Hydroxylapatite
  • Polylactic Acid
  • Polymethyl-methacrylate Microspheres (PMMA)
  • Fat Injection
  • Other Types
  • 6.2. Global Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Wrinkle Reduction
  • Facelift
  • Acne Scar Treatment
  • Lipoatrophy Treatment
  • Lip Enhancement
  • Other Applications
  • 6.3. Global Facial Injectable Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals And Ambulatory Surgery Centers
  • Dermatology And Cosmetic Clinics
  • Other End-Users

7. Facial Injectable Market Regional And Country Analysis

  • 7.1. Global Facial Injectable Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Facial Injectable Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Facial Injectable Market

  • 8.1. Asia-Pacific Facial Injectable Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Facial Injectable Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Facial Injectable Market

  • 9.1. China Facial Injectable Market Overview
  • 9.2. China Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Facial Injectable Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Facial Injectable Market

  • 10.1. India Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Facial Injectable Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Facial Injectable Market

  • 11.1. Japan Facial Injectable Market Overview
  • 11.2. Japan Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Facial Injectable Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Facial Injectable Market

  • 12.1. Australia Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Facial Injectable Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Facial Injectable Market

  • 13.1. Indonesia Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Facial Injectable Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Facial Injectable Market

  • 14.1. South Korea Facial Injectable Market Overview
  • 14.2. South Korea Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Facial Injectable Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Facial Injectable Market

  • 15.1. Western Europe Facial Injectable Market Overview
  • 15.2. Western Europe Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Facial Injectable Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Facial Injectable Market

  • 16.1. UK Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Facial Injectable Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Facial Injectable Market

  • 17.1. Germany Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Facial Injectable Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Facial Injectable Market

  • 18.1. France Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Facial Injectable Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Facial Injectable Market

  • 19.1. Italy Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Facial Injectable Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Facial Injectable Market

  • 20.1. Spain Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Facial Injectable Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Facial Injectable Market

  • 21.1. Eastern Europe Facial Injectable Market Overview
  • 21.2. Eastern Europe Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Facial Injectable Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Facial Injectable Market

  • 22.1. Russia Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Facial Injectable Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Facial Injectable Market

  • 23.1. North America Facial Injectable Market Overview
  • 23.2. North America Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Facial Injectable Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Facial Injectable Market

  • 24.1. USA Facial Injectable Market Overview
  • 24.2. USA Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Facial Injectable Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Facial Injectable Market

  • 25.1. Canada Facial Injectable Market Overview
  • 25.2. Canada Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Facial Injectable Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Facial Injectable Market

  • 26.1. South America Facial Injectable Market Overview
  • 26.2. South America Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Facial Injectable Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Facial Injectable Market

  • 27.1. Brazil Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Facial Injectable Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Facial Injectable Market

  • 28.1. Middle East Facial Injectable Market Overview
  • 28.2. Middle East Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Facial Injectable Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Facial Injectable Market

  • 29.1. Africa Facial Injectable Market Overview
  • 29.2. Africa Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Facial Injectable Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Facial Injectable Market Competitive Landscape And Company Profiles

  • 30.1. Facial Injectable Market Competitive Landscape
  • 30.2. Facial Injectable Market Company Profiles
    • 30.2.1. AbbVie Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Sanofi S.A.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Ipsen Pharma
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Galderma S.A.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Merz Pharma GmbH & Co. KGaA
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Facial Injectable Market Other Major And Innovative Companies

  • 31.1. Sinclair Pharma Plc
  • 31.2. Revance Therapeutics Inc.
  • 31.3. Suneva Medical Inc.
  • 31.4. Prollenium Medical Technologies
  • 31.5. SciVision Biotech Inc.
  • 31.6. Anteis S.A.
  • 31.7. Anika Therapeutics Inc.
  • 31.8. Q-Med AB
  • 31.9. Bloomage BioTechnology
  • 31.10. Medytox Inc.
  • 31.11. Teoxane Laboratories
  • 31.12. Alphaeon Corporation
  • 31.13. BIOPLUS CO. LTD.
  • 31.14. BioPolymer GmbH & Co. KG
  • 31.15. Bioxis Pharmaceuticals

32. Global Facial Injectable Market Competitive Benchmarking

33. Global Facial Injectable Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Facial Injectable Market

35. Facial Injectable Market Future Outlook and Potential Analysis

  • 35.1 Facial Injectable Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Facial Injectable Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Facial Injectable Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer